Amphinex

From WikiMD.org
Jump to navigation Jump to search

Amphinex

Amphinex (pronounced: am-fi-neks) is a proprietary name for a photosensitizing agent used in photodynamic therapy (PDT).

Etymology

The term "Amphinex" is derived from the Greek words 'amphi' meaning 'both' or 'double', and 'nex' which is a short form of 'nexus', meaning 'connection'. This could possibly refer to the dual action of the drug, which involves accumulation in cancer cells and activation by light to destroy the cells.

Usage

Amphinex is used in combination with a specific type of light to treat certain types of cancer. It is administered intravenously and accumulates in cancer cells. When these cells are exposed to light, Amphinex becomes activated and destroys the cancer cells.

Related Terms

  • Photodynamic therapy (PDT): A treatment that uses a drug, called a photosensitizer or photosensitizing agent, and a particular type of light to kill cancer cells.
  • Cancer: A group of diseases characterized by the uncontrolled growth and spread of abnormal cells.
  • Photosensitizer: A drug that makes cells more sensitive to light.
  • Intravenous (IV): A method of delivering medications or fluids directly into a vein.

See Also

External links

Esculaap.svg

This WikiMD article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski